INVESTOR BRIEFING March 2026 Aircraft carrier? Forward - Looking Statements Disclaimer BWX Technologies, Inc. ("BWXT") cautions that statements in this presentation that are forward-looking and provide other than historical information involve risks and uncertainties that may impact actual results and any future performance suggested in the forward-looking statements. The forward-looking statements in this presentation include, but are not limited to, statements relating to our 2026 and future strategic pri ...

Company Overview - BWX Technologies, Inc. (NYSE:BWXT) specializes in producing nuclear fuel and precision components for both government and commercial applications, including parts for naval reactors [2] - The company also manufactures medical radioisotopes and provides engineering and maintenance services for nuclear power plants throughout their operational lifespan [2] Financial Performance - BWX Technologies has seen significant stock performance, tripling in value over the past three years, with a 100% increase over the last 12 months and a 15% rise since the beginning of 2026 [1] - The company reported a strong quarterly performance, achieving a top and bottom line beat with a remarkable 95% sales growth from their commercial segment [1] - Management has issued a very optimistic full-year forecast, indicating confidence in continued growth [1] Industry Context - The defense contracting and nuclear energy sectors have been performing well, with the Pentagon's budget consistently increasing, benefiting companies like BWX Technologies [1]

Our Purpose: We employ nuclear technology to solve some of the world's most important problems Our Mission: We provide safe and effective nuclear solutions for global security, clean energy, environmental remediation, nuclear medicine, and space exploration Commitment to innovation, operational excellence, a strong safety record, and a focus on ensuring the highest ESG standards BWX Technologies, Inc. ("BWXT") cautions that statements in this presentation that are forward-looking and provide other than hist ...

Financial Performance - Revenue increased by 12%, driven by growth in both Government Operations and Commercial Operations segments; organic growth was up 4%[5,9] - Adjusted EBITDA increased by 16% and Non-GAAP EPS increased by 24%, driven by higher operating earnings and modestly higher other income[5,9] - Free Cash Flow was $126 million[5,9] - Record backlog reached $6.0 billion, up 70% year-over-year[5] Segment Performance - Government Operations revenue increased by 9%, with organic revenue up 6%, leading to an adjusted EBITDA margin of 22.6%[5,14] - Commercial Operations revenue increased by 24%, driven by double-digit medical growth and the Kinectrics acquisition, but organic revenue decreased by 3%[5,14] - Commercial Operations backlog of $1.6 billion, up 22% quarter-over-quarter and 136% year-over-year[5] Guidance - Revenue guidance raised to approximately $3.1 billion[5,17] - Adjusted EBITDA guidance raised to $565 million to $575 million[5,17] - Non-GAAP EPS guidance raised to $3.65 to $3.75[5,17] - Free Cash Flow guidance increased to $275 million to $285 million[5,17]